{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:55:40Z","timestamp":1794012940401,"version":"4.8.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","award":["Dr. Petrelli is supported by the Juvenile Diabetes"],"award-info":[{"award-number":["Dr. Petrelli is supported by the Juvenile Diabetes"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim\/hypothesis<\/jats:title>\n                    <jats:p>We assessed whether HOMA-IR and the Matsuda Index are associated with transitions through stages of type 1 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Autoantibody (AAb)-positive relatives of individuals with type 1 diabetes (\n                      <jats:italic>n<\/jats:italic>\n                      =6256) from the TrialNet Pathway to Prevention were studied. Associations of indicators of insulin resistance (HOMA-IR) and insulin sensitivity (Matsuda Index) with BMI percentile (BMIp) and age were assessed with adjustments for measures of insulin secretion, Index60 and insulinogenic index (IGI). Cox regression was used to determine if tertiles of HOMA-IR and Matsuda Index predicted transitions from Not Staged (&lt;2 AAbs) to Stage 1 (\u22652 AAbs and normoglycaemia), from Stage 1 to Stage 2 (\u22652 AAbs with dysglycaemia), and progression to Stage 3 (diabetes as defined by WHO\/ADA criteria).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were strong associations of HOMA-IR (positive) and Matsuda Index (inverse) with baseline age and BMIp (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.0001). After adjustments for Index60, transitioning from Stage 1 to Stage 2 was associated with higher HOMA-IR and lower Matsuda Index (HOMA-IR: HR=1.71,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.0001; Matsuda Index, HR=0.40,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.0001), as with progressing from Stages 1 or 2 to Stage 3 (HOMA-IR: HR=1.98,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.0001; Matsuda Index: HR=0.46,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.0001). Without adjustments, associations of progression to Stage 3 were inverse for HOMA-IR and positive for Matsuda Index, opposite in directionality with adjustments. When IGI was used in place of Index60, the findings were similar.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions\/interpretation<\/jats:title>\n                    <jats:p>Progression to Stages 2 and 3 of type 1 diabetes increases with HOMA-IR and decreases with the Matsuda Index after adjustments for insulin secretion. Indicators of insulin secretion appear helpful for interpreting associations of progression to type 1 diabetes with HOMA-IR or the Matsuda Index in AAb-positive relatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00125-023-06034-y","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T01:07:00Z","timestamp":1698887220000},"page":"290-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5639-9415","authenticated-orcid":false,"given":"Alessandra","family":"Petrelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cugnata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Carnovale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Bosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M.","family":"Libman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Piemonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cuthbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay M.","family":"Sosenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"issue":"Suppl 1","key":"6034_CR1","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1):S81-90","journal-title":"Diabetes Care"},{"issue":"1","key":"6034_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00125-015-3789-z","volume":"59","author":"RD Leslie","year":"2016","unstructured":"Leslie RD, Palmer J, Schloot NC, Lernmark A (2016) Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment. Diabetologia 59(1):13\u201320. https:\/\/doi.org\/10.1007\/s00125-015-3789-z","journal-title":"Diabetologia"},{"issue":"12","key":"6034_CR3","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrendo.2013.131","volume":"9","author":"LA Velloso","year":"2013","unstructured":"Velloso LA, Eizirik DL, Cnop M (2013) Type 2 diabetes mellitus\u2013an autoimmune disease? Nat Rev Endocrinol 9(12):750\u20135. https:\/\/doi.org\/10.1038\/nrendo.2013.131","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"6034_CR4","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00125-019-4909-y","volume":"62","author":"ER Pearson","year":"2019","unstructured":"Pearson ER (2019) Type 2 diabetes: a multifaceted disease. Diabetologia 62(7):1107\u201312. https:\/\/doi.org\/10.1007\/s00125-019-4909-y","journal-title":"Diabetologia"},{"key":"6034_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fendo.2019.00451","volume":"10","author":"P de Candia","year":"2019","unstructured":"de Candia P, Prattichizzo F, Garavelli S et al (2019) Type 2 diabetes: how much of an autoimmune disease? Front Endocrinol (Lausanne) 10:451. https:\/\/doi.org\/10.3389\/fendo.2019.00451","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"6034_CR6","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.2337\/dc19-0475","volume":"42","author":"BM Brooks-Worrell","year":"2019","unstructured":"Brooks-Worrell BM, Palmer JP (2019) Setting the stage for islet autoimmunity in type 2 diabetes: obesity-associated chronic systemic inflammation and endoplasmic reticulum (ER) stress. Diabetes Care 42(12):2338\u201346. https:\/\/doi.org\/10.2337\/dc19-0475","journal-title":"Diabetes Care"},{"issue":"10","key":"6034_CR7","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel RA, Dunne JL, Atkinson MA et al (2015) Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38(10):1964\u201374. https:\/\/doi.org\/10.2337\/dc15-1419","journal-title":"Diabetes Care"},{"issue":"7","key":"6034_CR8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/dom.14022","volume":"22","author":"R Buzzetti","year":"2020","unstructured":"Buzzetti R, Zampetti S, Pozzilli P (2020) Impact of obesity on the increasing incidence of type 1 diabetes. Diabetes Obes Metab 22(7):1009\u201313. https:\/\/doi.org\/10.1111\/dom.14022","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"6034_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1399-5448.2009.00519.x","volume":"11","author":"LL Liu","year":"2010","unstructured":"Liu LL, Lawrence JM, Davis C et al (2010) Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes 11(1):4\u201311. https:\/\/doi.org\/10.1111\/j.1399-5448.2009.00519.x","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"6034_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jpeds.2015.05.046","volume":"167","author":"SN DuBose","year":"2015","unstructured":"DuBose SN, Hermann JM, Tamborlane WV et al (2015) Obesity in youth with type 1 diabetes in Germany, Austria, and the United States. J Pediatr 167(3):627\u201332.e1-4. https:\/\/doi.org\/10.1016\/j.jpeds.2015.05.046","journal-title":"J Pediatr"},{"issue":"5","key":"6034_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2337\/dc16-2331","volume":"40","author":"CT Ferrara","year":"2017","unstructured":"Ferrara CT, Geyer SM, Liu YF et al (2017) Excess BMI in childhood: a modifiable risk factor for type 1 diabetes development? Diabetes Care 40(5):698\u2013701. https:\/\/doi.org\/10.2337\/dc16-2331","journal-title":"Diabetes Care"},{"issue":"10","key":"6034_CR12","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.2337\/diacare.26.10.2871","volume":"26","author":"IM Libman","year":"2003","unstructured":"Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ (2003) Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 26(10):2871\u20135. https:\/\/doi.org\/10.2337\/diacare.26.10.2871","journal-title":"Diabetes Care"},{"key":"6034_CR13","doi-asserted-by":"publisher","DOI":"10.2337\/db22-1263-P","author":"I Zucker","year":"2022","unstructured":"Zucker I, Zloof Y, Bardugo A et al (2022) Obesity in late adolescence and incident type 1 diabetes in young adulthood. Diabetologia. https:\/\/doi.org\/10.2337\/db22-1263-P","journal-title":"Diabetologia"},{"issue":"12","key":"6034_CR14","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2337\/diacare.23.12.1755","volume":"23","author":"E Hypponen","year":"2000","unstructured":"Hypponen E, Virtanen SM, Kenward MG, Knip M, Akerblom HK, Childhood Diabetes in Finland Study G (2000) Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 23(12):1755\u201360. https:\/\/doi.org\/10.2337\/diacare.23.12.1755","journal-title":"Diabetes Care"},{"issue":"9","key":"6034_CR15","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462\u201370. https:\/\/doi.org\/10.2337\/diacare.22.9.1462","journal-title":"Diabetes Care"},{"issue":"7","key":"6034_CR16","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.2337\/dc07-0358","volume":"30","author":"Y Song","year":"2007","unstructured":"Song Y, Manson JE, Tinker L et al (2007) Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women\u2019s Health Initiative Observational Study. Diabetes Care 30(7):1747\u201352. https:\/\/doi.org\/10.2337\/dc07-0358","journal-title":"Diabetes Care"},{"issue":"6","key":"6034_CR17","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s00125-016-3924-5","volume":"59","author":"FA Meah","year":"2016","unstructured":"Meah FA, DiMeglio LA, Greenbaum CJ et al (2016) The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants. Diabetologia 59(6):1186\u201395. https:\/\/doi.org\/10.1007\/s00125-016-3924-5","journal-title":"Diabetologia"},{"issue":"7","key":"6034_CR18","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1210\/jc.2008-2687","volume":"94","author":"X Ma","year":"2009","unstructured":"Ma X, Becker D, Arena VC, Vicini P, Greenbaum C (2009) The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of type 1 diabetic patients: a population analysis. J Clin Endocrinol Metab 94(7):2446\u201351. https:\/\/doi.org\/10.1210\/jc.2008-2687","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"6034_CR19","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1007\/s00125-009-1520-7","volume":"52","author":"M Stadler","year":"2009","unstructured":"Stadler M, Pacini G, Petrie J, Luger A, Anderwald C, Investigators R (2009) Beta cell (dys)function in non-diabetic offspring of diabetic patients. Diabetologia 52(11):2435\u201344. https:\/\/doi.org\/10.1007\/s00125-009-1520-7","journal-title":"Diabetologia"},{"issue":"3","key":"6034_CR20","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1210\/jc.2003-031503","volume":"89","author":"CW Yeckel","year":"2004","unstructured":"Yeckel CW, Weiss R, Dziura J et al (2004) Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 89(3):1096\u2013101. https:\/\/doi.org\/10.1210\/jc.2003-031503","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"6034_CR21","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.2337\/dc17-0916","volume":"40","author":"BM Nathan","year":"2017","unstructured":"Nathan BM, Boulware D, Geyer S et al (2017) Dysglycemia and index60 as prediagnostic end points for type 1 diabetes prevention trials. Diabetes Care 40(11):1494\u20139. https:\/\/doi.org\/10.2337\/dc17-0916","journal-title":"Diabetes Care"},{"issue":"2","key":"6034_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2337\/dc21-0944","volume":"45","author":"BM Nathan","year":"2022","unstructured":"Nathan BM, Redondo MJ, Ismail H et al (2022) Index60 identifies individuals at appreciable risk for stage 3 among an autoantibody-positive population with normal 2-hour glucose levels: implications for current staging criteria of type 1 diabetes. Diabetes Care 45(2):311\u20138. https:\/\/doi.org\/10.2337\/dc21-0944","journal-title":"Diabetes Care"},{"key":"6034_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1196\/annals.1447.054","volume":"1150","author":"JS Skyler","year":"2008","unstructured":"Skyler JS, Greenbaum CJ, Lachin JM et al (2008) Type 1 diabetes TrialNet\u2013an international collaborative clinical trials network. Ann N Y Acad Sci 1150:14\u201324. https:\/\/doi.org\/10.1196\/annals.1447.054","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"6034_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1399-5448.2008.00464.x","volume":"10","author":"JL Mahon","year":"2009","unstructured":"Mahon JL, Sosenko JM, Rafkin-Mervis L et al (2009) The TrialNet natural history study of the development of type 1 diabetes: objectives, design, and initial results. Pediatr Diabetes 10(2):97\u2013104. https:\/\/doi.org\/10.1111\/j.1399-5448.2008.00464.x","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"6034_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/jpm12040542","volume":"12","author":"C Deligne","year":"2022","unstructured":"Deligne C, You S, Mallone R (2022) Personalized immunotherapies for type 1 diabetes: who, what, when, and how? J Pers Med 12(4):542. https:\/\/doi.org\/10.3390\/jpm12040542","journal-title":"J Pers Med"},{"key":"6034_CR26","doi-asserted-by":"publisher","first-page":"1026416","DOI":"10.3389\/fimmu.2022.1026416","volume":"13","author":"C Bechi Genzano","year":"2022","unstructured":"Bechi Genzano C, Bezzecchi E, Carnovale D et al (2022) Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes. Front Immunol 13:1026416. https:\/\/doi.org\/10.3389\/fimmu.2022.1026416","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"6034_CR27","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"American Diabetes A","year":"2021","unstructured":"American Diabetes A (2021) 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care 44(Suppl 1):S15\u2013S33. https:\/\/doi.org\/10.2337\/dc21-S002","journal-title":"Diabetes Care"},{"issue":"10205","key":"6034_CR28","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/S0140-6736(19)32127-0","volume":"394","author":"CM Dayan","year":"2019","unstructured":"Dayan CM, Korah M, Tatovic D, Bundy BN, Herold KC (2019) Changing the landscape for type 1 diabetes: the first step to prevention. Lancet 394(10205):1286\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(19)32127-0","journal-title":"Lancet"},{"issue":"7","key":"6034_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412\u20139. https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"issue":"2","key":"6034_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2337\/dc14-1813","volume":"38","author":"JM Sosenko","year":"2015","unstructured":"Sosenko JM, Skyler JS, DiMeglio LA et al (2015) A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history. Diabetes Care 38(2):271\u20136. https:\/\/doi.org\/10.2337\/dc14-1813","journal-title":"Diabetes Care"},{"issue":"3","key":"6034_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.diabres.2005.10.005","volume":"72","author":"A Tura","year":"2006","unstructured":"Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract 72(3):298\u2013301. https:\/\/doi.org\/10.1016\/j.diabres.2005.10.005","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"6034_CR32","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3305\/nh.2013.28.5.6512","volume":"28","author":"S Henriquez","year":"2013","unstructured":"Henriquez S, Jara N, Bunout D et al (2013) Variability of formulas to assess insulin sensitivity and their association with the Matsuda index. Nutr Hosp 28(5):1594\u20138. https:\/\/doi.org\/10.3305\/nh.2013.28.5.6512","journal-title":"Nutr Hosp"},{"issue":"3","key":"6034_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1530\/EC-18-0021","volume":"7","author":"KC Lewandowski","year":"2018","unstructured":"Lewandowski KC, Plusajska J, Horzelski W, Bieniek E, Lewinski A (2018) Limitations of insulin resistance assessment in polycystic ovary syndrome. Endocr Connect 7(3):403\u201312. https:\/\/doi.org\/10.1530\/EC-18-0021","journal-title":"Endocr Connect"},{"issue":"3","key":"6034_CR34","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237(3):E214-23","journal-title":"Am J Physiol"},{"issue":"1","key":"6034_CR35","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1210\/jc.2012-2892","volume":"98","author":"BC Bergman","year":"2013","unstructured":"Bergman BC, Howard D, Schauer IE et al (2013) The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes. J Clin Endocrinol Metab 98(1):E40-50. https:\/\/doi.org\/10.1210\/jc.2012-2892","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6034_CR36","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1210\/jc.2011-3172","volume":"97","author":"BC Bergman","year":"2012","unstructured":"Bergman BC, Howard D, Schauer IE et al (2012) Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes. J Clin Endocrinol Metab 97(5):1663\u201372. https:\/\/doi.org\/10.1210\/jc.2011-3172","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6034_CR37","doi-asserted-by":"publisher","first-page":"E1174","DOI":"10.1152\/ajpendo.00279.2003","volume":"285","author":"G Perseghin","year":"2003","unstructured":"Perseghin G, Lattuada G, Danna M et al (2003) Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 285(6):E1174-81. https:\/\/doi.org\/10.1152\/ajpendo.00279.2003","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"6034_CR38","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1007\/s00125-005-0014-5","volume":"48","author":"G Perseghin","year":"2005","unstructured":"Perseghin G, Lattuada G, De Cobelli F et al (2005) Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes. Diabetologia 48(12):2615\u201321. https:\/\/doi.org\/10.1007\/s00125-005-0014-5","journal-title":"Diabetologia"},{"issue":"1","key":"6034_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/EJE-14-0911","volume":"173","author":"E Donga","year":"2015","unstructured":"Donga E, Dekkers OM, Corssmit EP, Romijn JA (2015) Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis. Eur J Endocrinol 173(1):101\u20139. https:\/\/doi.org\/10.1530\/EJE-14-0911","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"6034_CR40","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00125-004-1507-3","volume":"47","author":"S Fourlanos","year":"2004","unstructured":"Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC (2004) Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47(10):1661\u20137. https:\/\/doi.org\/10.1007\/s00125-004-1507-3","journal-title":"Diabetologia"},{"issue":"9","key":"6034_CR41","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1210\/clinem\/dgab344","volume":"106","author":"A Galderisi","year":"2021","unstructured":"Galderisi A, Moran A, Evans-Molina C et al (2021) Early impairment of insulin sensitivity, beta-cell responsiveness, and insulin clearance in youth with stage 1 type 1 diabetes. J Clin Endocrinol Metab 106(9):2660\u20139. https:\/\/doi.org\/10.1210\/clinem\/dgab344","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6034_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1530\/EJE-13-0206","volume":"169","author":"HT Siljander","year":"2013","unstructured":"Siljander HT, Hermann R, Hekkala A et al (2013) Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced beta-cell autoimmunity. Eur J Endocrinol 169(4):479\u201385. https:\/\/doi.org\/10.1530\/EJE-13-0206","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"6034_CR43","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2337\/dc07-0103","volume":"31","author":"PJ Bingley","year":"2008","unstructured":"Bingley PJ, Mahon JL, Gale EA, European Nicotinamide Diabetes Intervention Trial G (2008) Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care 31(1):146\u201350. https:\/\/doi.org\/10.2337\/dc07-0103","journal-title":"Diabetes Care"},{"issue":"6","key":"6034_CR44","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2337\/diacare.28.6.1415","volume":"28","author":"MI Hawa","year":"2005","unstructured":"Hawa MI, Bonfanti R, Valeri C, Delli Castelli M, Beyan H, Leslie RD (2005) No evidence for genetically determined alteration in insulin secretion or sensitivity predisposing to type 1 diabetes: a study of identical twins. Diabetes Care 28(6):1415\u20138. https:\/\/doi.org\/10.2337\/diacare.28.6.1415","journal-title":"Diabetes Care"},{"issue":"7","key":"6034_CR45","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s001250100548","volume":"44","author":"TJ Wilkin","year":"2001","unstructured":"Wilkin TJ (2001) The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 44(7):914\u201322. https:\/\/doi.org\/10.1007\/s001250100548","journal-title":"Diabetologia"},{"issue":"3","key":"6034_CR46","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2337\/diacare.29.03.06.dc05-1006","volume":"29","author":"JM Sosenko","year":"2006","unstructured":"Sosenko JM, Palmer JP, Greenbaum CJ et al (2006) Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 29(3):643\u20139. https:\/\/doi.org\/10.2337\/diacare.29.03.06.dc05-1006","journal-title":"Diabetes Care"},{"issue":"12","key":"6034_CR47","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.2337\/diab.45.12.1720","volume":"45","author":"PJ Bingley","year":"1996","unstructured":"Bingley PJ (1996) Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study. Diabetes 45(12):1720\u20138. https:\/\/doi.org\/10.2337\/diab.45.12.1720","journal-title":"Diabetes"},{"issue":"6","key":"6034_CR48","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/dom.13982","volume":"22","author":"HM Ismail","year":"2020","unstructured":"Ismail HM, Becker DJ, Libman I et al (2020) Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals. Diabetes Obes Metab 22(6):997\u20131000. https:\/\/doi.org\/10.1111\/dom.13982","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"6034_CR49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11892-021-01430-3","volume":"21","author":"A Petrelli","year":"2021","unstructured":"Petrelli A, Giovenzana A, Insalaco V, Phillips BE, Pietropaolo M, Giannoukakis N (2021) Autoimmune inflammation and insulin resistance: hallmarks so far and yet so close to explain diabetes endotypes. Curr Diab Rep 21(12):54. https:\/\/doi.org\/10.1007\/s11892-021-01430-3","journal-title":"Curr Diab Rep"},{"issue":"3","key":"6034_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.6065\/apem.2017.22.3.145","volume":"22","author":"SH Kim","year":"2017","unstructured":"Kim SH, Park MJ (2017) Effects of growth hormone on glucose metabolism and insulin resistance in human. Ann Pediatr Endocrinol Metab 22(3):145\u201352. https:\/\/doi.org\/10.6065\/apem.2017.22.3.145","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"Suppl 1","key":"6034_CR51","doi-asserted-by":"publisher","first-page":"S212","DOI":"10.2337\/diabetes.51.2007.s212","volume":"51","author":"RN Bergman","year":"2002","unstructured":"Bergman RN, Ader M, Huecking K, Van Citters G (2002) Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 51(Suppl 1):S212-20. https:\/\/doi.org\/10.2337\/diabetes.51.2007.s212","journal-title":"Diabetes"},{"issue":"9","key":"6034_CR52","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.2337\/dc10-0165","volume":"33","author":"C Lorenzo","year":"2010","unstructured":"Lorenzo C, Wagenknecht LE, Rewers MJ et al (2010) Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 33(9):2098\u2013103. https:\/\/doi.org\/10.2337\/dc10-0165","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-06034-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-023-06034-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-06034-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T03:02:51Z","timestamp":1705287771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-023-06034-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["6034"],"URL":"https:\/\/doi.org\/10.1007\/s00125-023-06034-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"29 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The data sets analysed for the present study are available from the corresponding author upon reasonable request.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"AP is supported by the JDRF (3-APF-2019-744-AN).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"AP was involved in the conception and design of the study, interpretated the data, drafted, revised and approved the final version of the article; FC and DCa performed statistical analysis, contributed to data interpretation, revised and approved the final version of the article; EB, IL and LP contributed to data interpretation, revised and approved the final version of the article; DCu performed data analysis, revised and approved the final version of the article; JS supervised data analysis, contributed to data interpretation, revised and approved the final version of the article. AP is the guarantor of this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}}]}}